Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Bon G;Pizzuti L;Laquintana V;Loria R;Porru M;Marchio C;Krasniqi E;Barba M;Maugeri-Sacca M;Gamucci T;Berardi R;Livi L;Ficorella C;Natoli C;Cortesi E;Generali D;La Verde N;Cassano A;Bria E;Moscetti L;Michelotti A;Adamo V;Zamagni C;Tonini G;Barchiesi G;Mazzotta M;Marinelli D;Tomao S;Marchetti P;Valerio MR;Mirabelli R;Russo A;Fabbri MA;D'Ostilio N;Veltri E;Corsi D;Garrone O;Paris I;Sarobba G;Giotta F;Garufi C;Cazzaniga M;Del Medico P;Roselli M;Sanguineti G;Sperduti I;Sapino A;De Maria R;Leonetti C;Di Leo A;Ciliberto G;Falcioni R;Vici P

2020-01-01